TissueGene Inc (950160)

Currency in KRW
17,660
+90(+0.51%)
Closed·
950160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16,25018,220
52 wk Range
11,470149,000
Key Statistics
Bid/Ask
17,650.00 / 17,660.00
Prev. Close
17,570
Open
17,720
Day's Range
16,250-18,220
52 wk Range
11,470-149,000
Volume
2.31M
Average Volume (3m)
1.69M
1-Year Change
-55.404%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
150,000
Upside
+749.38%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

TissueGene Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 150,000
(+749.38% Upside)

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-1,200.00 / -60.00
Revenue / Forecast
1.41B / --
EPS Revisions
Last 90 days

950160 Income Statement

Compare 950160 to Peers and Sector

Metrics to compare
950160
Peers
Sector
Relationship
P/E Ratio
−5.2x−9.0x−0.4x
PEG Ratio
0.01−0.270.00
Price/Book
12.0x2.5x2.6x
Price / LTM Sales
284.1x15.4x3.1x
Upside (Analyst Target)
-104.3%48.8%
Fair Value Upside
Unlock17.7%5.7%Unlock

Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
516.59K0.12%9.12B
Other Institutional Investors
51.10M12.03%902.45B
Public Companies & Retail Investors
373.23M87.85%6.59T
Total
424.85M100.00%7.5T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kolon Corporation9.37%39,826,575703,337,315
Kolon Life Science Inc.2.17%9,206,796162,592,017

People Also Watch

412,000
307950
-1.20%
317,000
006260
-3.50%
305,000
196170
+3.92%
58,300
103590
-1.02%
11,460
010170
+3.52%

FAQ

What Is the TissueGene (950160) Stock Price Today?

The TissueGene stock price today is 17,660 KRW.

What Stock Exchange Does TissueGene Trade On?

TissueGene is listed and trades on the KOSDAQ.

What Is the Stock Symbol for TissueGene?

The stock symbol for TissueGene is "950160."

What Is the TissueGene Market Cap?

As of today, TissueGene market cap is 1.5T KRW.

What Is TissueGene's Earnings Per Share (TTM)?

The TissueGene EPS (TTM) is -3,457.

From a Technical Analysis Perspective, Is 950160 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has TissueGene Stock Split?

TissueGene has split 0 times.

What is the current trading status of TissueGene (950160)?

As of Aug 09, 2026, TissueGene (950160) is trading at a price of 17,660 KRW, with a previous close of 17,570 KRW. The stock has fluctuated within a day range of 16,250 KRW to 18,220 KRW, while its 52-week range spans from 11,470 KRW to 149,000 KRW.

What Is TissueGene (950160) Price Target According to Analysts?

The average 12-month price target for TissueGene is 150,000 KRW, with a high estimate of 150000 KRW and a low estimate of 150000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +749.38% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.